title: The N-terminus of HIV-1 Tat protein is essential for Tat-TAR RNA interaction.
abstract: The human HIV transactivator protein Tat is essential for efficient viral transcription that occurs by a complex mechanism involving interaction of Tat with the TAR RNA element. This interaction appears to require the mediation of a cellular protein, cyclin T1. However, the possibility that Tat and TAR associate in a binary Tat-TAR complex has been little investigated. Using a chemically synthesized active Tat protein, the kinetic and equilibrium parameters of its interaction with TAR were determined by surface plasmon resonance technology. Independently of partner and method of immobilization onto the sensor chip, the association (k(a) = 5-9 x 10(5) M(-1) s(-1)) and dissociation rate constants (k(d) = 1.7-4.3 x 10(-3) s(-1)) yielded similar equilibrium dissociation constants (K(d) = 2-8 nM). A truncated peptide encompassing residues 30-86 of Tat did not bind to TAR at all. We conclude that Tat can form a high-affinity complex with TAR in the absence of cyclin T1 and that the N-terminal domain of Tat is essential for this interaction, suggesting a conformational link between this domain and the basic domain of Tat. These results are important in our quest for developing therapeutic compounds that impair viral replication.
authors.affiliation: UPR 9021, Institut de Biologie Moléculaire et Cellulaire, CNRS, 15 rue René Descartes, 67084 Strasbourg, France. o.chaloin@ibmc.u-strasbg.fr
authors.forename: O
authors.initials: O
authors.lastname: Chaloin
authors.forename: J-C
authors.initials: JC
authors.lastname: Peter
authors.forename: J-P
authors.initials: JP
authors.lastname: Briand
authors.forename: B
authors.initials: B
authors.lastname: Masquida
authors.forename: C
authors.initials: C
authors.lastname: Desgranges
authors.forename: S
authors.initials: S
authors.lastname: Muller
authors.forename: J
authors.initials: J
authors.lastname: Hoebeke
mesh_terms: D015696:Gene Products, tat / Q000737:chemistry / Q000378:metabolism*; D006801:Humans; D007103:Immobilization; D007700:Kinetics; D040081:Protein Array Analysis; D011485:Protein Binding / Q000502:physiology; D012367:RNA, Viral / Q000737:chemistry / Q000378:metabolism*; D011994:Recombinant Proteins / Q000737:chemistry / Q000378:metabolism; D019809:Streptavidin / Q000737:chemistry; D013329:Structure-Activity Relationship; D020349:Surface Plasmon Resonance; D013997:Time Factors
chemical_list: D015696:Gene Products, tat; D012367:RNA, Viral; D011994:Recombinant Proteins; D019809:Streptavidin
references.citation: Lancet. 2013 Feb 23;381(9867):629-38
references.pmid: 23439102
references.citation: N Engl J Med. 2009 Mar 5;360(10):961-72
references.pmid: 19228612
references.citation: N Engl J Med. 2015 Oct 29;373(18):1709-19
references.pmid: 26466202
references.citation: Eur Heart J. 2016 Jan 14;37(3):267-315
references.pmid: 26320110
references.citation: Eur Heart J. 2010 Oct;31(20):2501-55
references.pmid: 20802248
references.citation: N Engl J Med. 2012 Dec 20;367(25):2375-84
references.pmid: 23121323
references.citation: N Engl J Med. 2009 Jan 15;360(3):213-24
references.pmid: 19144937
references.citation: Eur Heart J. 2014 Oct 1;35(37):2541-619
references.pmid: 25173339
references.citation: N Engl J Med. 2012 Sep 13;367(11):991-1001
references.pmid: 22924638